Efficacy and Safety of Twice-Daily Insulin Lispro Low Mixture Compared to a Once-Daily Long Acting Insulin Comparator in Patients Who Have Been Using One or More Oral Antihyperglycemic Agents Without Insulin - Related Studies

Efficacy and Safety of Twice-Daily Insulin Lispro Low Mixture Compared to a Once-Daily Long Acting Insulin Comparator in Patients Who Have Been Using One or More Oral Antihyperglycemic Agents Without Insulin

This study has been completed.

Study NCT00036504. Last updated on July 18, 2006. Information provided by Eli Lilly and Company

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Type 2 Diabetes Mellitus

2	Additional conditions recognized in this trial
		Diabetes Mellitus
		Diabetes Mellitus, Type 2

3	More general conditions related to this trial
		Endocrine System Diseases
		Glucose Metabolism Disorders
		Metabolic Diseases

4	Interventions listed in this trial
		Insulin Lispro low mixture

5	Additional drug interventions recognized in this trial
		Insulin
		Insulin LISPRO
		Insulin, Long-Acting

6	More general drug interventions related to this trial
		Hypoglycemic Agents
		Pharmacologic Actions
		Physiological Effects of Drugs

7	Sponsors listed in this trial
		Eli Lilly and Company